# Healthpeak Properties, Inc.: Form 10-Q for the period ended Mar 31, 2012

- Company: [Healthpeak Properties, Inc.](/companies/doc.md) (CIK 765880)
- Form: 10-Q
- Filed: 2012-05-01
- Accepted by EDGAR: May 1, 2012, 08:33 ET
- Period: 2012-03-31
- Accession: 0001104659-12-030975
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/765880/000110465912030975/a12-8339_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/765880/000110465912030975/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-01-01 to 2012-03-31 | $459.0m | us-gaap:Revenues |
| Interest expense | 3 months, 2012-01-01 to 2012-03-31 | $104.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2012-01-01 to 2012-03-31 | −$709.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2012-01-01 to 2012-03-31 | $193.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2012-01-01 to 2012-03-31 | $0.43 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2012-01-01 to 2012-03-31 | $0.43 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2012-01-01 to 2012-03-31 | 411,661,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2012-01-01 to 2012-03-31 | $186.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 3 months, 2012-01-01 to 2012-03-31 | $211.1m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | at 2012-03-31 | $347.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2012-03-31 | $17.73bn | us-gaap:Assets |
| Total liabilities | at 2012-03-31 | $8.42bn | us-gaap:Liabilities |
| Long-term debt | at 2012-03-31 | $7.62bn | us-gaap:LongTermDebt |
| Shareholders' equity | at 2012-03-31 | $9.12bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 52,743 characters.

### Cautionary Language Regarding Forward-Looking Statements

Statements in this Quarterly Report on Form 10-Q that are not historical factual statements are “forward-looking statements.” We intend to have our forward-looking statements covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with those provisions. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectations as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “forecast,” “plan,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof. In addition, we, through our officers, from time to time, make forward-looking oral and written public statements concerning our expected future operations, strategies, securities offerings, growth and investment opportunities, dispositions, capital structure changes, budgets and other developments. Readers are cautioned that, while forward-looking statements reflect our good faith belief and reasonable assumptions based upon current information, we can give no assurance that our expectations or forecasts will be attained. Therefore, readers should be mindful that forward-looking statements are not guarantees of future performance and that they are subject to known and unknown risks and uncertainties that are difficult to predict. As more fully set forth under “Part I, Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, factors that may cause our actual results to differ materially from the expectations contained in the forward-looking statements include:

(a) Changes in national and local economic conditions, including a prolonged period of weak economic growth;

(b) Continued volatility in the capital markets, including changes in interest rates and the availability and cost of capital;

(c) Our ability to manage our indebtedness level and changes in the terms of such indebtedness;

(d) Changes in federal, state or local laws and regulations, including those affecting the healthcare industry that affect our costs of compliance or increase the costs, or otherwise affect the operations of our operators, tenants and borrowers;

(e) The potential impact of future litigation matters, including the possibility of larger than expected litigation costs, adverse results and related developments;

(f) Competition for tenants and borrowers, including with respect to new leases and mortgages and the renewal or rollover of existing leases;

(g) Our ability to negotiate the same or better terms with new tenants or operators if existing leases are not renewed or we exercise our right to replace an existing operator or tenant upon default;

(h) Availability of suitable properties to acquire at favorable prices and the competition for the acquisition and financing of those properties;

(i) The financial, legal, regulatory and reputational difficulties of significant operators of our properties;

(j) The risk that we may not be able to achieve the benefits of investments within expected time-frames or at all, or within expected cost projections;

(k) The ability to obtain financing necessary to consummate acquisitions on favorable terms;

(l) Changes in the reimbursement available to our operators, tenants and borrowers by governmental or private payors (including the July 2011 Centers for Medicare & Medicaid Services final rule reducing Medicare skilled nursing facility Prospective Payment System payments in FY 2012 by 11.1% compared to FY 2011) and other potential changes in Medicare and Medicaid payment levels, which, among other effects, could negatively impact the value of our approximate 10% equity interest in the operations of HCR ManorCare;

(m) The risks associated with our investments in joint ventures and unconsolidated entities, including our lack of sole decision making authority and our reliance on our joint venture partners’ financial condition and continued cooperation;

(n) The ability of our operators, tenants and borrowers to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and to generate sufficient income to make rent and loan payments to us and our ability to recover investments made, if applicable, in their operations; and

(o) The financial weakness of some operators and tenants, including potential bankruptcies and downturns in their businesses, which results in uncertainties regarding our ability to continue to realize the full benefit of such operators’ and/or tenants’ leases.

Except as required by law, we undertake no, and hereby disclaim any, obligation to update any forward-looking statements, whether as a result of new information, changed circumstances or otherwise.

The information set forth in this Item 2 is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. We will discuss and provide our analysis in the following order:

- Executive Summary
- 2012 Transaction Overview
- Dividends
- Critical Accounting Policies
- Results of Operations
- Liquidity and Capital Resources
- Funds from Operations
- Off-Balance Sheet Arrangements
- Contractual Obligations
- Inflation
- Recent Accounting Pronouncements

### Executive Summary

We are a self-administered real estate investment trust (“REIT”) that, together with our unconsolidated joint ventures, invests primarily in real estate serving the healthcare industry in the United States (“U.S.”). We acquire, develop, lease, manage and dispose of healthcare real estate, and provide financing to healthcare providers. At March 31, 2012, our portfolio of investments, including properties in our Investment Management Platform, consisted of interests in 1,012 facilities. Our Investment Management Platform represents the following joint ventures: (i) HCP Ventures III, LLC, (ii) HCP Ventures IV, LLC and (iii) the HCP Life Science ventures.

Our business strategy is based on three principles: (i) opportunistic investing, (ii) portfolio diversification and (iii) conservative financing. We actively redeploy capital from investments with lower return potential into investments with higher return potential. We make investments where the expected risk-adjusted return exceeds our cost of capital and strive to capitalize on our operator, tenant and other business relationships to grow our business.

Our strategy contemplates acquiring and developing properties on terms that are favorable to us. Generally, we prefer larger, more complex private transactions that leverage our management team’s experience and our infrastructure. We follow a disciplined approach to enhancing the value of our existing portfolio, including ongoing evaluation of potential disposition of properties that no longer fit our strategy.

We primarily generate revenue by leasing healthcare properties under long-term leases with fixed or inflation indexed escalators. Most of our rents and other earned income from leases are received under triple-net leases or leases that provide for substantial recovery of operating expenses; however, some of our medical office and life science leases are structured as gross or modified gross leases. Accordingly, for such medical office buildings (“MOBs”) and life science facilities, we incur certain property operating expenses, such as real estate taxes, repairs and maintenance, property management fees, utilities and insurance. Our growth for these assets depends, in part, on our ability to (i) increase rental income and other earned income from leases by increasing rental rates and occupancy levels; (ii) maximize tenant recoveries given underlying lease structures; and (iii) control operating and other expenses. Our operations are impacted by property specific, market specific, general economic and other conditions. At March 31, 2012, the contractual maturities in our portfolio of leased assets were 11% through 2014 (measured in dollars of expiring rents).

Access to capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as to fund future acquisitions and development through the issuance of additional securities or secured debt. Access to external capital on favorable terms is critical to the success of our strategy.

### 2012 Transaction Overview

#### Financing Activities

On January 23, 2012, we issued $450 million of 3.75% senior unsecured notes due in 2019; net proceeds from the offering were $444 million.

On March 22, 2012, we priced a $359 million offering of nine million shares of common stock at $39.93 per share with the proceeds used primarily to redeem all outstanding shares of our preferred stock.

On March 22, 2012, we announced the redemption of the 4,000,000 shares of 7.25% Series E and 7,820,000 shares of 7.10% Series F preferred stock at a price of $25.00 per share, or $295.5 million in aggregate, plus all accrued and unpaid dividends to April 23, 2012 (the redemption date). As a result of the redemption, we incurred a charge of $10.4 million related to the original issuance costs of the preferred stock and recognized an incremental preferred stock dividend of $1.3 million representing the acceleration of the accrued dividend from April 1, 2012 to the redemption date (the aggregate charge of $11.7 million is presented as an additional first quarter preferred stock dividend in our consolidated income statements).

On March 27, 2012, we completed an amendment to our existing $1.5 billion unsecured revolving line of credit facility. We improved the pricing and extended the maturity of the facility one additional year to March 2016. Based on our current credit ratings, the amended facility bears interest annually at one-month London Interbank Offered Rate (“LIBOR”) plus 1.075% and has a facility fee of 0.175%, which in the aggregate represent a 55 basis point reduction to our funded interest cost.

#### Investment Transactions

During the quarter ended March 31, 2012, we made investments of $40 million to fund development and other capital projects, primarily in our life science and senior housing segments and sold a medical office building for $7 million, recognizing a gain of $3 million.

### Dividends

On April 26, 2012, we announced that our Board declared a quarterly common stock cash dividend of $0.50 per share. The common stock dividend will be paid on May 22, 2012 to stockholders of record as of the close of business on May 7, 2012.

### Critical Accounting Policies

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires our management to use judgment in the application of accounting policies, including making estimates and assumptions. We base estimates on the best information available to us at the time, our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our condensed consolidated financial statements. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. A summary of our critical accounting policies is included in our Annual Report on Form 10-K for the year ended December 31, 2011 in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”; our critical accounting policies have not changed during 2012.

### Results of Operations

We evaluate our business and allocate resources among our five business segments: (i) senior housing, (ii) post-acute/skilled nursing, (iii) life science, (iv) medical office and (v) hospital. Under the senior housing, life science, post-acute/skilled nursing and hospital segments, we invest or co-invest primarily in single operator or tenant properties, through the acquisition and development of real estate, management of operations and by debt issued by operators in these sectors. Under the medical office segment, we invest or co-invest through the acquisition and development of MOBs that are leased under gross, modified gross or triple-net leases, generally to multiple tenants, and which generally require a greater level of property management.

We use net operating income (“NOI”) and adjusted NOI to assess and compare property level performance, including our same property portfolio (“SPP”), and to make decisions about resource allocations. We believe these measures provide investors relevant and useful information because they reflect only income and operating expense items that are incurred at the property level and present them on an unleveraged basis. We believe that net income is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income as defined by GAAP since NOI excludes certain components from net income. Further, NOI may not be comparable to that of other REITs, as they may use different methodologies for calculating NOI. See Note 14 to the Condensed Consolidated Financial Statements for additional segment information and the relevant reconciliations from net income to NOI and adjusted NOI.

Operating expenses are generally related to MOB and life science properties and senior housing properties managed on our behalf (“RIDEA properties”). We generally recover all or a portion of MOB and life science expenses from the tenants (tenant recoveries). The presentation of expenses as operating or general and administrative is based on the underlying nature of the expense. Periodically, we review the classification of expenses between categories and make revisions based on changes in the underlying nature of the expenses.

Our evaluation of results of operations by each business segment includes an analysis of our SPP and our total property portfolio. SPP information allows us to evaluate the performance of our leased property portfolio under a consistent population by eliminating changes in the composition of our portfolio of properties. We identify our SPP as stabilized properties that remained in operations and were consistently reported as leased properties or RIDEA properties for the duration of the year-over-year comparison periods presented. Accordingly, it takes a stabilized property a minimum of 12 months in operations under a consistent reporting structure to be included in our SPP. Newly acquired operating assets are generally considered stabilized at the earlier of lease-up (typically when the tenant(s) controls the physical use of at least 80% of the space) or 12 months from the acquisition date. Newly completed developments, including redevelopments, are considered stabilized at the earlier of lease-up or 24 months from the date the property is placed in service. SPP NOI excludes certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis.

#### Comparison of the Three Months Ended March 31, 2012 to the Three Months Ended March 31, 2011

#### Segment NOI and Adjusted NOI

The tables below provide selected operating information for our SPP and total property portfolio for each of our five business segments. Our consolidated SPP consists of 570 properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2011 and that remained in operations under a consistent reporting structure through March 31, 2012. Our consolidated total property portfolio represents 938 and 601 properties at March 31, 2012 and 2011, respectively, and excludes properties sold during the period from January 1, 2011 to March 31, 2012.

### Senior Housing

Results are as of and for the three months ended March 31, 2012 and 2011 (dollars in thousands except per unit data):

|  | SPP 2012 | 2011 | Change | Total Portfolio 2012 | 2011 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $96,660 | $96,771 | $(111) | $116,362 | $109,510 | $6,852 |
| Resident fees and services | 1,048 | 2,505 | (1,457) | 36,179 | 2,505 | 33,674 |
| Total revenues | $97,708 | $99,276 | $(1,568) | $152,541 | $112,015 | $40,526 |
| Operating expenses | (239) | (514) | 275 | (21,630) | (985) | (20,645) |
| NOI | $97,469 | $98,762 | $(1,293) | $130,911 | $111,030 | $19,881 |
| Straight-line rents | (7,897) | (10,113) | 2,216 | (8,149) | (10,112) | 1,963 |
| DFL accretion | (1,939) | (2,675) | 736 | (5,149) | (2,675) | (2,474) |
| Amortization of above and below market lease intangibles, net | (631) | (631) | — | (597) | (631) | 34 |
| Adjusted NOI | $87,002 | $85,343 | $1,659 | $117,016 | $97,612 | $19,404 |
| SPP adjusted NOI % change |  |  | 1.9% |  |  |  |
| Property count(2) | 223 | 223 |  | 314 | 248 |  |
| Average capacity (units)(3) | 25,636 | 25,545 |  | 35,964 | 30,319 |  |
| Average annual rent per unit(4) | $13,612 | $13,444 |  | $13,115 | $13,007 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the three months ended March 31, 2011, we removed three senior housing properties from SPP that were sold or classified as held for sale from April 1, 2011 to March 31, 2012; the property-level results of these properties are classified in discontinued operations.

(3) Represents average capacity as reported by the respective tenants or operators for three months in arrears from the periods presented.

(4) Average annual rent per unit for operating properties under a RIDEA structure is based on NOI.

*Senior Housing SPP NOI and Adjusted NOI.* Adjusted NOI improved primarily from leases in our SPP subject to annual rent escalations; these rent escalations typically do not improve SPP NOI because our leases are generally straight-lined. These increases were partially offset by a decrease in resident fees and services revenue, which relates to certain working capital adjustments from properties that were previously transitioned from Sunrise to another operator.

*Senior Housing Total Portfolio NOI and Adjusted NOI.* Including the impact of our SPP, our total portfolio NOI and adjusted NOI increased for the three months ended March 31, 2012 primarily from income from 66 senior housing leased properties classified as DFLs that were acquired on April 7, 2011 from HCR ManorCare, Inc. (see Note 3 and Note 6 to the Condensed Consolidated Financial Statements for additional information regarding the HCR ManorCare Acquisition and Net Investments in DFLs, respectively).

Additionally, HCP Ventures II was consolidated on January 14, 2011 (see Note 8 to the Condensed Consolidated Financial Statements for additional information), resulting in us recognizing rental and related revenues for the 25 leased properties commencing on that date. On September 1, 2011, for 21 of these 25 properties, we entered into management contracts in a structure permitted by RIDEA (see Note 12 to the Condensed Consolidated Financial Statements for additional information), resulting in the termination of the properties’ leases. For these 21 properties that are now in a RIDEA structure, the resident-level revenues and related operating expenses are reported in our condensed consolidated financial statements beginning on that date. Under the provisions of RIDEA, a REIT may lease “qualified healthcare properties” on an arm’s length basis to a taxable REIT subsidiary if the property is operated on behalf of such subsidiary by a person who qualifies as an “eligible independent contractor.”

### Post-Acute/Skilled Nursing

Results are as of and for the three months ended March 31, 2012 and 2011 (dollars in thousands, except per bed data):

|  | SPP 2012 | 2011 | Change | Total Portfolio 2012 | 2011 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $9,616 | $9,440 | $176 | $133,995 | $9,440 | $124,555 |
| Operating expenses | (51) | (15) | (36) | (200) | (20) | (180) |
| NOI | $9,565 | $9,425 | $140 | $133,795 | $9,420 | $124,375 |
| Straight-line rents | (164) | (323) | 159 | (163) | (323) | 160 |
| DFL accretion | — | — | — | (20,473) | — | (20,473) |
| Amortization of above and below market lease intangibles, net | — | — | — | 11 | — | 11 |
| Adjusted NOI | $9,401 | $9,102 | $299 | $113,170 | $9,097 | $104,073 |
| SPP adjusted NOI % change |  |  | 3.3% |  |  |  |
| Property count | 45 | 45 |  | 313 | 45 |  |
| Average capacity (beds)(2) | 5,238 | 5,259 |  | 40,042 | 5,259 |  |
| Average annual rent per bed | $7,218 | $6,935 |  | $11,324 | $6,935 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) Represents average capacity as reported by the respective tenants or operators for three months in arrears from the periods reported.

*Post-Acute/Skilled Nursing Total Portfolio NOI and Adjusted NOI.* Total portfolio NOI and adjusted NOI for the three months ended March 31, 2012 primarily increased as a result of 268 post-acute/skilled nursing leased properties classified as DFLs that were acquired on April 7, 2011 from HCR ManorCare, Inc. (see Notes 3 and 6 to the Condensed Consolidated Financial Statements for additional information regarding the HCR ManorCare Acquisition and Net Investments in DFLs, respectively).

### Life Science

Results are as of and for the three months ended March 31, 2012 and 2011 (dollars and square feet in thousands, except per sq. ft. data):

|  | SPP 2012 | 2011 | Change | Total Portfolio 2012 | 2011 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $60,830 | $61,054 | $(224) | $61,410 | $61,617 | $(207) |
| Tenant recoveries | 10,279 | 10,715 | (436) | 10,420 | 10,808 | (388) |
| Total revenues | $71,109 | $71,769 | $(660) | $71,830 | $72,425 | $(595) |
| Operating expenses | (11,687) | (12,012) | 325 | (12,884) | (12,838) | (46) |
| NOI | $59,422 | $59,757 | $(335) | $58,946 | $59,587 | $(641) |
| Straight-line rents | 340 | (4,159) | 4,499 | 81 | (4,315) | 4,396 |
| Amortization of above and below market lease intangibles, net | 89 | (41) | 130 | 77 | (59) | 136 |
| Lease termination fees | — | (1,589) | 1,589 | — | (1,589) | 1,589 |
| Adjusted NOI | $59,851 | $53,968 | $5,883 | $59,104 | $53,624 | $5,480 |
| SPP adjusted NOI % change |  |  | 10.9% |  |  |  |
| Property count | 101 | 101 |  | 108 | 104 |  |
| Occupancy | 91.1% | 90.2% |  | 89.1% | 89.0% |  |
| Average occupied sq. ft. | 6,079 | 6,027 |  | 6,146 | 6,082 |  |
| Average annual rent per occupied sq. ft. | $47 | $44 |  | $47 | $44 |  |

*Life Science SPP NOI and Adjusted NOI.* SPP adjusted NOI increased primarily as a result of a $4 million rent payment in connection with a February 2012 amendment to a lease, which will be recognized as rental income on a straight-line basis in future periods. SPP NOI decreased year-over-year as a result of a lease termination fee earned during the three months ended March 31, 2011; no similar termination fees were earned during the three months ended March 31, 2012.

*Life Science Total Portfolio NOI and Adjusted NOI.* Total portfolio adjusted NOI increased primarily as a result of the impact of our SPP discussed above.

During the three months ended March 31, 2012, 289,000 square feet of new and renewal leases commenced at an average monthly rate of $28.55 per square foot compared to 235,000 square feet of expiring and terminated leases with an average monthly rate of $31.86 per square foot.

### Medical Office

Results are as of and for the three months ended March 31, 2012 and 2011 (dollars and square feet in thousands, except per sq. ft. data):

|  | SPP 2012 | 2011 | Change | Total Portfolio 2012 | 2011 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $67,384 | $66,651 | $733 | $68,297 | $67,527 | $770 |
| Tenant recoveries | 11,271 | 11,926 | (655) | 11,658 | 12,043 | (385) |
| Total revenues | $78,655 | $78,577 | $78 | $79,955 | $79,570 | $385 |
| Operating expenses | (29,736) | (30,288) | 552 | (31,705) | (32,035) | 330 |
| NOI | $48,919 | $48,289 | $630 | $48,250 | $47,535 | $715 |
| Straight-line rents | (1,301) | (2,088) | 787 | (1,359) | (2,115) | 756 |
| Amortization of above and below market lease intangibles, net | 54 | 82 | (28) | 30 | 2 | 28 |
| Adjusted NOI | $47,672 | $46,283 | $1,389 | $46,921 | $45,422 | $1,499 |
| SPP adjusted NOI % change |  |  | 3.0% |  |  |  |
| Property count(1) | 185 | 185 |  | 186 | 187 |  |
| Occupancy | 91.1% | 90.8% |  | 91.2% | 91.0% |  |
| Average occupied sq. ft. | 11,671 | 11,634 |  | 11,844 | 11,790 |  |
| Average annual rent per occupied sq. ft. | $26 | $26 |  | $26 | $26 |  |

(1) From our past presentation of SPP for the three months ended March 31, 2011, we removed (i) a MOB that was sold or classified as held for sale from April 1, 2011 to March 31, 2012; the property-level results of this property are classified in discontinued operations; and (ii) a MOB that was placed into redevelopment in 2012, which no longer meets our criteria for SPP as of the date it was placed into redevelopment.

*Medical Office SPP NOI and Adjusted NOI.* SPP NOI and SPP adjusted NOI increased year-over-year primarily as a result of rent escalations and a modest improvement in medical office occupancy.

*Medical Office Total Portfolio NOI and Adjusted NOI.* Total portfolio adjusted NOI increased primarily as a result of the impact of our SPP discussed above.

During the three months ended March 31, 2012, 440,000 square feet of new and renewal leases commenced at an average monthly rate of $22.66 per square foot compared to 628,000 square feet of expiring and terminated leases with an average monthly rate of $21.11 per square foot (includes 143,000 square feet related to properties that were sold or placed into redevelopment with an average monthly rate of $15.59 per square foot).

### Hospital

Results are as of and for the three months ended March 31, 2012 and 2011 (dollars in thousands, except rent per bed data):

|  | SPP 2012 | 2011 | Change | Total Portfolio 2012 | 2011 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $18,042 | $17,517 | $525 | $18,806 | $18,382 | $424 |
| Tenant recoveries | 572 | 594 | (22) | 572 | 593 | (21) |
| Total revenues | $18,614 | $18,111 | $503 | $19,378 | $18,975 | $403 |
| Operating expenses | (929) | (965) | 36 | (930) | (967) | 37 |
| NOI | $17,685 | $17,146 | $539 | $18,448 | $18,008 | $440 |
| Straight-line rents | (184) | (275) | 91 | (337) | (435) | 98 |
| Amortization of above and below market lease intangibles, net | (192) | (193) | 1 | (218) | (218) | — |
| Adjusted NOI | $17,309 | $16,678 | $631 | $17,893 | $17,355 | $538 |
| SPP adjusted NOI % change |  |  | 3.8% |  |  |  |
| Property count | 16 | 16 |  | 17 | 17 |  |
| Capacity (beds)(1) | 2,379 | 2,361 |  | 2,379 | 2,361 |  |
| Average annual rent per bed | $30,667 | $29,891 |  | $31,649 | $31,041 |  |

(1) Represents capacity as reported by the respective tenants or operators for three months in arrears from the date reported. Certain operators in our hospital portfolio are not required under their respective leases to provide operational data.

*Hospital SPP NOI and Adjusted NOI.* SPP NOI and adjusted NOI increased for the three months ended March 31, 2012 primarily as a result of additional rents, caused by certain hospitals exceeding specified facility-level revenue base amounts or thresholds that yield additional rents to us.

*Hospital Total Portfolio NOI and Adjusted NOI.* Total portfolio adjusted NOI increased primarily as a result of the impact of our SPP discussed above.

#### Other Income and Expense Items

#### Interest income

Interest income decreased $37.3 million to $0.8 million for the three months ended March 31, 2012. The decrease was primarily the result of the following: (i) a decrease of $29.2 million as a result of the repayment and early settlement of our HCR ManorCare debt investments in 2011 and (ii) a decrease of $8.2 million as a result of the early repayment of our loans to Genesis in 2011.

#### Interest expense

Interest expense decreased $4.0 million to $104.6 million for the three months ended March 31, 2012. The decrease was principally due to the $11.3 million write-off of unamortized loan fees related to a terminated bridge loan commitment during the three months ended March 31, 2011, partially offset by an increase of $7.4 million resulting from our senior unsecured notes offerings in January 2011 and January 2012, net of related maturities of certain senior unsecured notes during 2011.

The table below sets forth information with respect to our debt, excluding premiums and discounts (dollars in thousands):

| Balance: | As of March 31,(1) 2012 | 2011 |
| --- | ---: | ---: |
| Fixed rate | $7,607,626 | $7,344,311 |
| Variable rate | 48,835 | 299,538 |
| Total | $7,656,461 | $7,643,849 |
| **Percent of total debt:** |  |  |
| Fixed rate | 99% | 96% |
| Variable rate | 1 | 4 |
| Total | 100% | 100% |
| **Weighted average interest rate at end of period:** |  |  |
| Fixed rate | 5.72% | 5.84% |
| Variable rate | 1.44% | 4.11% |
| Total weighted average rate | 5.69% | 5.77% |

(1) Excludes $87 million and $91 million of other debt at March 31, 2012 and 2011, respectively, that represent non-interest bearing life care bonds and occupancy fee deposits at certain of our senior housing facilities, which have no scheduled maturities.

#### Depreciation and amortization expense

Depreciation and amortization expense decreased $2.9 million to $88.2 million for the three months ended March 31, 2012. The decrease was primarily the result of a change in the estimated useful life of an asset in 2011, which caused an incremental charge during the three months ended March 31, 2011. No similar change in estimate was made that resulted in an incremental charge during the three months ended March 31, 2012.

#### General and administrative expenses

General and administrative expenses decreased $1.9 million to $20.1 million for the three months ended March 31, 2012. The decrease was primarily due to a decrease in acquisition costs and compensation related expenses, partially offset by an increase in legal fees.

#### Other income, net

Other income, net, decreased $9.9 million to $0.4 million for the three months ended March 31, 2012. The decrease was primarily the result of a gain of $8 million resulting from our acquisition of our partner’s 65% interest in and consolidation of HCP Ventures II in January 2011 (see Note 8 to the Condensed Consolidated Financial Statements for additional information). No similar gain upon consolidation was recognized during the three months ended March 31, 2012.

#### Equity income from unconsolidated joint ventures

Equity income from unconsolidated joint ventures increased $12.9 million to $13.7 million for the three months ended March 31, 2012. The increase was primarily the result of equity income from HCR ManorCare (see Notes 3 and 8 to the Condensed Consolidated Financial Statements for additional information), partially offset by the impact of our consolidation of HCP Ventures II on January 14, 2011 (see Note 8 to the Condensed Consolidated Financial Statements for additional information), which was previously accounted for as an equity method investment.

#### Discontinued operations

During the three months ended March 31, 2012, we sold one property for $7 million, realizing a gain of $2.9 million. There were no sales of properties during the three months ended March 31, 2011.

#### Preferred stock dividends

On March 22, 2012, we announced the redemption of all outstanding shares of preferred stock. On April 23, 2012, the shares of our preferred stock were redeemed, plus all accrued and unpaid dividends to the redemption date. During the three months ended March 31, 2012, we incurred a redemption charge of $10.4 million related to the original issuance costs of the preferred stock, and recognized an additional preferred stock dividend of $1.3 million representing the acceleration of the accrued dividend from April 1, 2012 to the redemption date (the aggregate charge of $11.7 million is presented as an additional preferred stock dividend in our consolidated income statements).

### Liquidity and Capital Resources

Our principal liquidity needs are to: (i) fund recurring operating expenses, (ii) meet debt service requirements including principal payments and maturities in the last nine months of 2012, (iii) fund capital expenditures, including tenant improvements and leasing costs, (iv) fund acquisition and development activities, and (v) make dividend distributions. We believe these needs will be satisfied using cash flows generated by operations and from our various financing activities during the next twelve months. During the three months ended March 31, 2012, distributions to shareholders and noncontrolling interest holders exceeded cash flows from operations by approximately $29 million. During 2012, we raised aggregate net proceeds of $803 million from issuances of debt and common stock, which proceeds, among other things, were the sources of cash used to fund the excess of distributions to shareholders and noncontrolling interest holders above cash flows from operations during the three months ended March 31, 2012.

We anticipate making future investments dependent on the availability of cost-effective sources of capital. We intend to use our revolving line of credit facility and the public capital markets as our principal sources of financing. As of April 25, 2012, we had credit ratings of Baa2 (stable) from Moody’s, BBB (positive) from S&P and BBB+ (stable) from Fitch on our senior unsecured debt securities.

Net cash provided by operating activities was $186 million and $150 million for the three months ended March 31, 2012 and 2011, respectively. The increase in operating cash flows is primarily the result of the following: (i) the additive impact of our investments in 2011, (ii) assets placed in service during 2011 and 2012 and (iii) rent escalations and resets in 2011 and 2012, which increases were partially offset by increased debt interest payments. Our cash flows from operations are dependent upon the occupancy level of multi-tenant buildings, rental rates on leases, our tenants’ performance on their lease obligations, the level of operating expenses and other factors.

Net cash used in investing activities was $31 million and $576 million for the three months ended March 31, 2012 and 2011, respectively. The cash used in investing activities for the three months ended March 31, 2012 principally reflects the net effect of: (i) $22 million used for development of real estate, (ii) $10 million used for investments in loans receivable and (iii) $9 million used for leasing costs and tenant and capital improvements, which were partially offset by (i) $7 million of proceeds from the sale of real estate and (ii) $4 million received from the repayments from our investments in loans receivable.

Net cash provided by financing activities was $159 million and $3.4 billion for the three months ended March 31, 2012 and 2011, respectively. The cash provided by financing activities for the three months ended March 31, 2012 consisted primarily of: (i) the issuance of $450 million of senior unsecured notes and (ii) net proceeds of $398 million from the issuances of common stock and exercise of stock options. The amount of cash provided by financing activities was partially offset by: (i) net repayments under our revolving line of credit facility of $454 million, (ii) payments of common and preferred dividends aggregating $211 million, (iii) repayment of mortgage debt of $10 million and (iv) debt issuance and origination costs (deferred financing costs) of $10 million.

#### Debt

#### Bank Line of Credit

On March 27, 2012, we executed an amendment to our existing $1.5 billion unsecured revolving line of credit facility (the “Facility”). This amendment reduces the cost to us of the Facility (lower borrowing rate and facility fee) and extends the Facility’s maturity by one additional year to March 2016. The Facility contains a one-year extension option. Borrowings under this Facility accrue interest at LIBOR plus a margin that depends upon our debt ratings. We pay a facility fee on the entire revolving commitment that depends on our debt ratings. Based on our debt ratings at April 25, 2012, the margin on the Facility was 1.075%, and the facility fee was 0.175%. We have the right to increase the commitments under the Facility by an aggregate amount of up to $500 million, subject to customary conditions. At March 31, 2012, we had no balance outstanding under this Facility.

Our Facility contains certain financial restrictions and other customary requirements. Among other things, these covenants, using terms defined in the agreement (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Secured Debt to Consolidated Total Asset Value to 30%, (iii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 60%, (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times and (v) require a formula-determined Minimum Consolidated Tangible Net Worth of $8.0 billion at March 31, 2012. At March 31, 2012, we were in compliance with each of these restrictions and requirements of the Facility.

Our Facility also contains cross-default provisions to other indebtedness of ours, including in some instances, certain mortgages on our properties. Certain mortgages contain default provisions relating to defaults under the leases or operating agreements on the applicable properties by our operators or tenants, including default provisions relating to the bankruptcy filings of such operator or tenant. Although we believe that we would be able to secure amendments under the applicable agreements if a default as described above occurs, such a default may result in significantly less favorable borrowing terms than currently available, material delays in the availability of funding or other material adverse consequences.

#### Senior Unsecured Notes

At March 31, 2012, we had senior unsecured notes outstanding with an aggregate principal balance of $5.9 billion. Interest rates on the notes ranged from 1.37% to 7.07% with a weighted average effective interest rate of 5.57% and a weighted average maturity of 6.15 years at March 31, 2012. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms. We believe we were in compliance with these covenants at March 31, 2012.

#### Mortgage Debt

At March 31, 2012, we had $1.8 billion in aggregate principal amount of mortgage debt outstanding that is secured by 138 healthcare facilities (including redevelopment properties) with a carrying value of $2.2 billion. Interest rates on the mortgage debt ranged from 1.94% to 8.75% with a weighted average effective interest rate of 6.12% and a weighted average maturity of 4.13 years at March 31, 2012.

Mortgage debt generally requires monthly principal and interest payments, is collateralized by certain properties and is generally non-recourse. Mortgage debt typically restricts transfer of the encumbered properties, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires maintenance of insurance on the assets and includes conditions to obtain lender consent to enter into and terminate material leases. Some of the mortgage debt is also cross-collateralized by multiple properties and may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.

#### Other Debt

At March 31, 2012, we had $87 million of non-interest bearing life care bonds at two of our continuing care retirement communities and non-interest bearing occupancy fee deposits at two of our senior housing facilities, all of which were payable to certain residents of the facilities (collectively, “Life Care Bonds”). At March 31, 2012, $30 million of the Life Care Bonds were refundable to the residents upon the resident moving out or to their estate upon death, and $57 million of the Life Care Bonds were refundable after the unit is successfully remarketed to a new resident.

#### Debt Maturities

The following table summarizes our stated debt maturities and scheduled principal repayments at March 31, 2012 (in thousands):

| Year | Amount(1) |
| --- | ---: |
| 2012 (Nine months) | $307,955 |
| 2013 | 917,374 |
| 2014 | 670,758 |
| 2015 | 702,102 |
| 2016 | 1,185,586 |
| Thereafter | 3,872,687 |
|  | 7,656,462 |
| (Discounts) and premiums, net | (35,270) |
|  | $7,621,192 |

(1) Excludes $87 million of other debt that represents Life Care Bonds that have no scheduled maturities.

#### Derivative Instruments

We use derivative instruments to mitigate the effects of interest rate fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. We do not use derivative instruments for speculative or trading purposes.

The following table summarizes our outstanding interest rate swap contracts as of March 31, 2012 (dollars in thousands):

| Date Entered | Maturity Date | Hedge Designation | Fixed Rate | Floating Rate Index | Notional Amount | Fair Value |
| --- | --- | --- | ---: | --- | ---: | ---: |
| July 2005(1) | July 2020 | Cash Flow | 3.82% | BMA Swap Index | $45,600 | $(7,447) |
| November 2008 | October 2016 | Cash Flow | 5.95% | 1 Month LIBOR+1.50% | 27,500 | (4,028) |
| July 2009 | July 2013 | Cash Flow | 6.13% | 1 Month LIBOR+3.65% | 13,900 | (372) |

(1) Represents three interest-rate swap contracts with an aggregate notional amount of $45.6 million.

For a more detailed description of our derivative instruments, see Note 20 to the Condensed Consolidated Financial Statements and Item 3. *Quantitative and Qualitative Disclosures About Market Risk.*

#### Equity

At March 31, 2012, we had 419.4 million shares of common stock outstanding. At March 31, 2012, equity totaled $9.3 billion, and our equity securities had a market value of $16.8 billion.

At March 31, 2012, there were a total of 4.2 million DownREIT units outstanding in five limited liability companies in which we are the managing member. The DownREIT units are exchangeable for an amount of cash approximating the then-current market value of shares of our common stock or, at our option, shares of our common stock (subject to certain adjustments, such as stock splits and reclassifications).

#### Shelf Registration

We have a prospectus on file with the U.S. Securities and Exchange Commission (“SEC”) as part of a registration statement on Form S-3, using a shelf registration process which expires in September 2012. Under this “shelf” process, we may sell from time to time any combination of the registered securities in one or more offerings. The securities described in the prospectus include common stock, preferred stock and debt securities. Each time we sell securities under the shelf registration, we will provide a prospectus supplement that will contain specific information about the terms of the securities being offered and of the offering. We may offer and sell the securities pursuant to this prospectus from time to time in one or more of the following ways: through underwriters or dealers, through agents, directly to purchasers or through a combination of any of these sale methods. Proceeds from the sale of these securities may be used for general corporate purposes, which may include repayment of indebtedness, working capital and potential acquisitions.

### Funds From Operations (“FFO”)

We believe FFO applicable to common shares, diluted FFO applicable to common shares, and basic and diluted FFO per common share are important supplemental non-GAAP measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that uses historical cost accounting for depreciation could be less informative. The term FFO was designed by the REIT industry to address this issue.

FFO is defined as net income applicable to common shares (computed in accordance with GAAP), excluding gains or losses from acquisition and dispositions of depreciable real estate or related interests, impairments of, or related to, depreciable real estate, plus real estate and DFL depreciation and amortization, with adjustments for joint ventures. Adjustments for joint ventures are calculated to reflect FFO on the same basis. FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income. We compute FFO in accordance with the current National Association of Real Estate Investment Trusts’ (“NAREIT”) definition; however, other REITs may report FFO differently or have a different interpretation of the current NAREIT definition from us. In addition, we present FFO before the impact of litigation settlement charges, preferred stock redemption charges, impairments (recoveries) of non-depreciable assets and merger-related items (defined below) (“FFO as adjusted”). Management believes FFO as adjusted is a useful alternative measurement. This measure is a modification of the NAREIT definition of FFO and should not be used as an alternative to net income (determined in accordance with GAAP).

Details of certain items that affect comparability are discussed under *Results of Operations* above. The following is a reconciliation from net income applicable to common shares, the most direct comparable financial measure calculated and presented in accordance with GAAP, to FFO and FFO as adjusted (in thousands, except per share data):

|  | Three Months Ended March 31, 2012 | 2011 |
| --- | ---: | ---: |
| Net income applicable to common shares | $175,257 | $63,875 |
| Depreciation and amortization of real estate, in-place lease and other intangibles: |  |  |
| Continuing operations | 88,241 | 91,182 |
| Discontinued operations | 35 | 238 |
| DFL depreciation | 3,050 | 372 |
| Gain on sales of real estate | (2,856) | — |
| Gain upon consolidation of joint venture | — | (8,039) |
| Equity income from unconsolidated joint ventures | (13,675) | (798) |
| FFO from unconsolidated joint ventures | 16,177 | 3,315 |
| Noncontrolling interests’ and participating securities’ share in earnings | 4,301 | 4,826 |
| Noncontrolling interests’ and participating securities’ share in FFO | (5,724) | (5,282) |
| FFO applicable to common shares | 264,806 | 149,689 |
| Distributions on dilutive convertible units | 3,122 | — |
| Diluted FFO applicable to common shares | $267,928 | $149,689 |
| Diluted FFO per common share | $0.64 | $0.40 |
| Weighted average shares used to calculate diluted FFO per common share | 417,524 | 373,960 |
| Impact of adjustments to FFO: |  |  |
| Preferred stock redemption charge(1) | $10,432 | $— |
| Merger-related items(2) | — | 32,308 |
|  | $10,432 | $32,308 |
| FFO as adjusted applicable to common shares | $275,238 | $181,997 |
| Distributions on dilutive convertible units and other | 3,089 | 1,733 |
| Diluted FFO as adjusted | $278,327 | $183,730 |
| Diluted FFO as adjusted per common share | $0.67 | $0.56 |
| Weighted average shares used to calculate diluted FFO as adjusted per common share | 417,524 | 330,286 (3) |

(1) In connection with the redemption of our preferred stock, during the three months ended March 31, 2012, we incurred a redemption charge of $10.4 million related to the original issuance costs.

(2) Merger-related items for 2011 include the following: (i) $10.3 million of direct transaction costs, net; and (ii) $22.0 million of interest expense associated with the $2.4 billion senior unsecured notes offering completed on January 24, 2011, which proceeds were obtained to prefund the HCR ManorCare Acquisition.

(3) Our weighted average shares used to calculate diluted FFO as adjusted eliminate the impact of our December 2010 46 million shares common stock offering and 30 million shares from our March 2011 common stock offering (excludes 4.5 million shares sold to the underwriters upon exercise of their option to purchase additional shares), which issuances increased our weighted average shares by 47.3 million for the three months ended March 31, 2011. Proceeds from these offerings were used to fund a portion of the cash consideration for the HCR ManorCare Acquisition.

### Off-Balance Sheet Arrangements

We own interests in certain unconsolidated joint ventures as described under Note 8 to the Condensed Consolidated Financial Statements. Except in limited circumstances, our risk of loss is limited to our investment in the joint venture and any outstanding loans receivable. In addition, we have certain properties which serve as collateral for debt that is owed by a previous owner of certain of our facilities, as described under Note 12 to the Condensed Consolidated Financial Statements. Our risk of loss for these certain properties is limited to the outstanding debt balance plus penalties, if any. We have no other material off-balance sheet arrangements that we expect would materially affect our liquidity and capital resources except those described below under *Contractual Obligations.*

### Contractual Obligations

The following table summarizes our material contractual payment obligations and commitments at March 31, 2012 (in thousands):

|  | Total(1) | Less than One Year | 2013-2014 | 2015-2016 | More than Five Years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Senior unsecured notes | $5,887,000 | $250,000 | $1,037,000 | $1,300,000 | $3,300,000 |
| Mortgage debt | 1,769,462 | 57,955 | 551,132 | 587,688 | 572,687 |
| Construction loan commitments(2) | 80,474 | 59,789 | 20,685 | — | — |
| Development commitments(3) | 30,549 | 28,949 | 1,600 | — | — |
| Ground and other operating leases | 201,353 | 4,235 | 10,476 | 8,355 | 178,287 |
| Interest(4) | 2,538,263 | 264,482 | 727,611 | 568,397 | 977,773 |
| Total | $10,507,101 | $665,410 | $2,348,504 | $2,464,440 | $5,028,747 |

(1) Excludes $87 million of other debt that represents Life Care Bonds that have no scheduled maturities.

(2) Represents commitments to finance development projects and related working capital financings.

(3) Represents construction and other commitments for developments in progress.

(4) Interest on variable-rate debt is calculated using rates in effect at March 31, 2012.

### Inflation

Our leases often provide for either fixed increases in base rents or indexed escalators, based on the Consumer Price Index or other measures, and/or additional rent based on increases in the tenants’ operating revenues. Substantially all of our MOB leases require the tenant to pay a share of property operating costs such as real estate taxes, insurance and utilities. Substantially all of our senior housing, life science, post-acute/skilled nursing and hospital leases require the operator or tenant to pay all of the property operating costs or reimburse us for all such costs. We believe that inflationary increases in expenses will be offset, in part, by the operator or tenant expense reimbursements and contractual rent increases described above.

### Recent Accounting Pronouncements

There were no accounting pronouncements that were issued, but not yet adopted by us, that we believe will materially impact our condensed consolidated financial statements.

## Market risk

As filed, 3,406 characters.

*Interest Rate Risk.* At March 31, 2012, we were exposed to market risks related to fluctuations in interest rates on properties with a gross value of $83 million that are subject to leases where the payments fluctuate with changes in LIBOR. Our exposure to income fluctuations related to our variable-rate investments is partially offset by: (i) $25 million of variable-rate senior unsecured notes and (ii) $24 million of variable-rate mortgage debt payable (excludes $87 million of variable-rate mortgage notes that have been hedged through interest-rate swap contracts).

Interest rate fluctuations will generally not affect our future earnings or cash flows on our fixed rate debt and assets unless such instruments mature or are otherwise terminated. However, interest rate changes will affect the fair value of our fixed rate instruments. Conversely, changes in interest rates on variable rate debt and investments would change our future earnings and cash flows, but not significantly affect the fair value of those instruments. Assuming a one percentage point increase in the interest rate related to the variable-rate investments and variable-rate debt, and assuming no other changes in the outstanding balance as of March 31, 2012, interest income would increase by approximately $0.3 million, or less than $0.01 per common share on a diluted basis.

We use derivative financial instruments in the normal course of business to mitigate interest rate risk. We do not use derivative financial instruments for speculative or trading purposes. Derivatives are recorded on the condensed consolidated balance sheets at their fair value. See Note 20 to the Condensed Consolidated Financial Statements for additional information.

To illustrate the effect of movements in the interest rate markets, we performed a market sensitivity analysis on our hedging instruments. We applied various basis point spreads to the underlying interest rate curves of the derivative portfolio in order to determine the instruments’ change in fair value. Assuming a one percentage point change in the underlying interest rate curve, the estimated change in fair value of each of the underlying derivative instruments would not exceed $3.7 million. See Note 20 to the Condensed Consolidated Financial Statements for additional analysis details.

*Market Risk.* We have investments in marketable equity securities classified as available-for-sale. Gains and losses on these securities are recognized in income when realized, and losses are recognized when an other-than-temporary decline in value is identified. An initial indicator of other-than-temporary decline in value for marketable equity securities is based on the severity of the decline in market value below the cost basis for an extended period of time. We consider a variety of factors in evaluating an other-than-temporary decline in value, such as: the length of time and the extent to which the market value has been less than our current cost basis; the issuer’s financial condition, capital strength and near-term prospects; any recent events specific to that issuer and economic conditions of its industry; and our investment horizon in relationship to an anticipated near-term recovery in the market value, if any. At March 31, 2012, the fair value and current cost basis of marketable equity securities was $18.4 million and $17.1 million, respectively.

## Controls and procedures

As filed, 2,280 characters.

*Disclosure Controls and Procedures.* We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Also, we have investments in certain unconsolidated entities. Our disclosure controls and procedures with respect to such entities are substantially more limited than those we maintain with respect to our consolidated subsidiaries.

As required by Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2012. Based upon that evaluation, our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

*Changes in Internal Control Over Financial Reporting.* There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 161 characters.

There are no material changes to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2011.

Filed May 1, 2012.
Source: SEC EDGAR, the filing index for accession 0001104659-12-030975. Last ingested by Listed: Nov 14, 2026, 21:09 ET. No prices; not investment advice.
